Wells Fargo initiated coverage of Bio-Rad with an Equal Weight rating and $340 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on BIO: Bio-Rad Laboratories Welcomes New President and COO Bio-Rad Labcorp announces Jon DiVincenzo as COO OncoCyte announces successful GraftAssure beta launch Bio-Rad board to increase share repurchase program Bio-Rad cuts FY24 revenue growth view to (4%)-(2.5%) from (2.5%)-(1%) Disclaimer & DisclosureReport an Issue